Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;34(7):1625-35.
doi: 10.1002/hbm.22019. Epub 2012 Feb 22.

Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging

Affiliations

Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging

Cristina Sánchez-Castañeda et al. Hum Brain Mapp. 2013 Jul.

Abstract

Neurodegeneration of the striatum in Huntington disease (HD) is characterized by loss of medium-spiny neurons, huntingtin nuclear inclusions, reactive gliosis, and iron accumulation. Neuroimaging allows in vivo detection of the macro- and micro-structural changes that occur from presymptomatic stages of the disease (preHD). The aim of our study was to evaluate the reliability of multimodal imaging as an in vivo biomarker of vulnerability and development of the disease and to characterize macro- and micro-structural changes in subcortical nuclei in HD. Macrostructure (T1-weighted images), microstructure (diffusion tensor imaging), and iron content (R 2* relaxometry) of subcortical nuclei and medial temporal lobe structures were evaluated by a 3 T scanner in 17 preHD carriers, 12 early-stage patients and 29 matched controls. We observed a volume reduction and microstructural changes in the basal ganglia (caudate, putamen, and globus pallidus) and iron accumulation in the globus pallidus in both preHD and symptomatic subjects; all these features were significantly more pronounced in patients, in whom degeneration extended to the other subcortical nuclei (i.e., thalamus and accumbens). Mean diffusivity (MD) was the most powerful predictor in models explaining more than 50% of the variability in HD development in the caudate, putamen, and thalamus. These findings suggest that the measurement of MD may further enhance the well-known predictive value of striatal volume to assess disease progression as it is highly sensitive to tissue microimpairment. Multimodal imaging may detect brain changes even in preHD stages.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram showing volume (mm3), R 2*, MD, and FA mean values from the seven structures considered. *Significant differences between preHD and control preHD; as well as between HD and control HD. Significant differences between preHD and HD subjects. (A) Volume mean values, (B) R 2* mean values, (C) MD mean values, and (D) FA mean values.

References

    1. Aylward E, Sparks BF, Field KM, Yallapragada V, Shpritz BD, Rosenblatt A, Brandt J, Gourley LM, Liang K, Zhou H, Margolis RL, Ross CA ( 2004): Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63: 66–72. - PubMed
    1. Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, Barta PE, Pearlson GD, Ross CA (2000): Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 15: 552–560. - PubMed
    1. Aylward EH, Liu D, Nopoulos PC, Ross CA, Pierson RK, Mills JA, Long JD, Paulsen JS; PREDICT‐HD Investigators and Coordinators of the Huntington Study Group (2011): Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident Cases. Biol Psychiatry (in press) - PMC - PubMed
    1. Aylward EH, Nopoulos PC, Ross CA, Langbehn DR, Pierson RK, Mills JA, Johnson HJ, Magnotta VA, Juhl AR, Paulsen JS; PREDICT‐HD Investigators and Coordinators of Huntington Study Group ( 2011): Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82: 405–410. - PMC - PubMed
    1. Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J ( 1999): Increased basal ganglia iron levels in Huntington disease. Arch Neurol 56: 569–574. - PubMed

Publication types

MeSH terms